Biotechnology
The Biotechnology industry has a total of 586 stocks, with a combined market cap of $1.23 trillion and total revenue of $109.76 billion.
Market Cap
1.23T
Revenue
109.76B
Profits
-40.61B
PE Ratio
n/a
Profit Margin
-37.00%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.83B | 0.55% | 577,075 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 68.49B | 2.62% | 381,072 | 14.92B |
| 3 | ARGX | argenx SE | 57.28B | -2.29% | 209,225 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.83B | -0.98% | 920,877 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.54B | 3.46% | 934,847 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 36.38B | 0.41% | 199,847 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.97B | 0.29% | 734,513 | 2.44B |
| 8 | ROIV | Roivant Sciences Ltd. | 24.96B | -0.89% | 2,012,893 | 8.26M |
| 9 | INCY | Incyte Corporation | 23.90B | 1.65% | 1,526,775 | 5.36B |
| 10 | BNTX | BioNTech SE | 23.24B | 2.88% | 415,347 | 3.23B |
| 11 | INSM | Insmed Incorporated | 22.89B | -1.23% | 1,040,181 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 21.99B | 2.50% | 3,386,021 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.56B | 0.42% | 1,176,348 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.77B | 0.22% | 201,037 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.54B | 0.39% | 1,057,979 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.99B | 0.29% | 363,936 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.09B | 1.23% | 1,160,607 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.78B | 1.80% | 189,240 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.32B | -0.68% | 319,131 | 708.24M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.13B | 0.64% | 1,327,083 | 622.01M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.75B | 2.46% | 748,231 | 3.24B |
| 22 | TECH | Bio-Techne Corporation | 11.18B | 0.19% | 2,672,521 | 1.21B |
| 23 | ABVX | ABIVAX Société Anonyme | 11.10B | 0.87% | 365,750 | 5.67M |
| 24 | CYTK | Cytokinetics, Incorporated | 11.03B | 0.64% | 1,003,946 | 105.82M |
| 25 | SMMT | Summit Therapeutics Inc. | 10.79B | -0.95% | 2,440,723 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 10.36B | 4.88% | 233,751 | 417.30M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.09B | 0.04% | 443,740 | - |
| 28 | CORT | Corcept Therapeutics Incorporated | 9.72B | -5.04% | 666,327 | 769.10M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.70B | -0.13% | 813,431 | 1.51B |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 9.23B | -1.18% | 1,353,237 | 1.06B |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.17B | 0.77% | 211,915 | 51.48M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | -1.63% | 157,183 | 7.46M |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.23% | 4,314,732 | 18.07M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 8.82B | -1.84% | 357,617 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.78B | 0.25% | 212,295 | 74.06M |
| 36 | IMVT | Immunovant, Inc. | 8.32B | 2.23% | 349,036 | - |
| 37 | PCVX | Vaxcyte, Inc. | 8.03B | 1.79% | 359,320 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.95B | 0.09% | 931,057 | 700.35M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.39B | 5.66% | 298,180 | 217.17M |
| 40 | IBRX | ImmunityBio, Inc. | 7.29B | -1.90% | 6,979,274 | 140.98M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.96B | 0.96% | 156,924 | 569.61M |
| 42 | COGT | Cogent Biosciences, Inc. | 6.90B | 1.58% | 782,456 | - |
| 43 | ERAS | Erasca, Inc. | 6.63B | - | 2,016,875 | - |
| 44 | CGON | CG Oncology, Inc. | 6.41B | 4.88% | 419,156 | 5.07M |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.34B | 0.31% | 270,485 | 7.50M |
| 46 | PTCT | PTC Therapeutics, Inc. | 6.33B | -0.62% | 839,206 | 827.11M |
| 47 | BLTE | Belite Bio, Inc | 6.16B | 2.17% | 101,900 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.98B | 4.66% | 549,294 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.85B | -1.69% | 253,323 | 274.48M |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.78B | 1.79% | 189,049 | 1.34M |
| 51 | DFTX | Definium Therapeutics, Inc. | 5.71B | -0.41% | 1,061,515 | - |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.52B | -0.61% | 351,867 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.29B | -0.80% | 777,928 | 536.20M |
| 54 | DYN | Dyne Therapeutics, Inc. | 4.79B | 4.97% | 1,915,578 | - |
| 55 | MANE | Veradermics, Incorporated | 4.76B | 4.10% | 263,848 | - |
| 56 | CRSP | CRISPR Therapeutics AG | 4.63B | 1.10% | 711,275 | 4.10M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.45B | 1.30% | 423,519 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 4.40B | 0.26% | 2,106,443 | 907.29M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.40B | 3.38% | 568,321 | 1.10B |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.12B | 2.01% | 1,030,870 | - |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.11B | 2.17% | 978,770 | 10.68M |
| 62 | CELC | Celcuity Inc. | 4.06B | 0.81% | 785,780 | - |
| 63 | PBLS | Parabilis Medicines, Inc. | 4.02B | 0.90% | 147,999 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.89B | 1.09% | 1,198,383 | 56.99M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.79B | 3.33% | 964,947 | - |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.71B | 0.30% | 479,471 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.66B | -14.81% | 7,777,965 | 1.14B |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.55B | 2.33% | 626,548 | 22.57M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.53B | -1.20% | 461,612 | 236.00M |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | 2.38% | 560,746 | 415.62M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.49B | -0.16% | 303,985 | - |
| 72 | ALMS | Alumis Inc. | 3.47B | -2.68% | 650,171 | 8.40M |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.46B | 2.94% | 339,671 | 225.27M |
| 74 | TLX | Telix Pharmaceuticals Limited | 3.39B | -2.84% | 88,478 | 803.79M |
| 75 | MBX | MBX Biosciences, Inc. | 2.91B | -1.40% | 158,601 | - |
| 76 | IRON | Disc Medicine, Inc. | 2.88B | 1.58% | 139,341 | - |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.84B | 2.44% | 430,243 | 865.00K |
| 78 | RARE | Ultragenyx Pharmaceutical Inc. | 2.66B | 0.74% | 678,703 | 670.00M |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | - | 7,158,396 | 3.49M |
| 80 | QURE | uniQure N.V. | 2.65B | -0.95% | 925,633 | 18.09M |
| 81 | KOD | Kodiak Sciences Inc. | 2.65B | 2.54% | 235,483 | - |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | 3.78% | 432,834 | 535.08M |
| 83 | IMNM | Immunome, Inc. | 2.61B | 3.65% | 317,453 | 4.02M |
| 84 | TRVI | Trevi Therapeutics, Inc. | 2.57B | 3.28% | 819,101 | - |
| 85 | VERA | Vera Therapeutics, Inc. | 2.56B | 0.48% | 604,319 | - |
| 86 | BEAM | Beam Therapeutics Inc. | 2.53B | 1.43% | 943,640 | 164.01M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.45B | 4.25% | 420,133 | - |
| 88 | NRIX | Nurix Therapeutics, Inc. | 2.45B | 0.90% | 634,350 | 36.77M |
| 89 | NKTR | Nektar Therapeutics | 2.37B | -0.67% | 337,319 | 55.63M |
| 90 | PHVS | Pharvaris N.V. | 2.37B | -0.70% | 111,406 | - |
| 91 | VCEL | Vericel Corporation | 2.35B | 2.00% | 154,511 | 292.09M |
| 92 | COAG | Hemab Therapeutics Holdings, Inc. | 2.33B | 5.39% | 269,488 | - |
| 93 | NUVB | Nuvation Bio Inc. | 2.29B | 2.65% | 4,175,623 | 143.05M |
| 94 | KLRA | Kailera Therapeutics, Inc. | 2.28B | -0.51% | 279,377 | - |
| 95 | AGIO | Agios Pharmaceuticals, Inc. | 2.23B | 2.98% | 492,686 | 66.05M |
| 96 | IOVA | Iovance Biotherapeutics, Inc. | 2.20B | -1.20% | 9,414,321 | 285.61M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 3.37% | 1,177,706 | 70.92M |
| 98 | BHVN | Biohaven Ltd. | 2.20B | 1.96% | 1,095,913 | - |
| 99 | SLS | SELLAS Life Sciences Group, Inc. | 2.11B | -5.04% | 7,819,156 | - |
| 100 | ZLAB | Zai Lab Limited | 2.09B | -3.02% | 475,716 | 453.28M |
| 101 | HRMY | Harmony Biosciences Holdings, Inc. | 2.09B | 2.35% | 310,672 | 899.11M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.08B | 5.27% | 98,790 | - |
| 103 | SION | Sionna Therapeutics, Inc. | 2.07B | 0.53% | 285,652 | - |
| 104 | ZBIO | Zenas BioPharma, Inc. | 2.07B | 7.77% | 595,340 | 10.00M |
| 105 | NBTX | Nanobiotix S.A. | 2.02B | 0.25% | 79,419 | 38.27M |
| 106 | URGN | UroGen Pharma Ltd. | 2.01B | 0.90% | 284,234 | 140.49M |
| 107 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 3.21% | 195,999 | 20.00M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | 0.98% | 747,780 | 298.30M |
| 109 | ADMA | ADMA Biologics, Inc. | 1.98B | 3.33% | 984,863 | 509.86M |
| 110 | MESO | Mesoblast Limited | 1.95B | -4.80% | 238,711 | 65.38M |
| 111 | PGEN | Precigen, Inc. | 1.94B | 1.02% | 3,595,140 | 31.60M |
| 112 | GLUE | Monte Rosa Therapeutics, Inc. | 1.94B | 0.57% | 620,389 | 42.95M |
| 113 | KARD | Kardigan, Inc. | 1.93B | 3.90% | 90,550 | - |
| 114 | GHRS | GH Research PLC | 1.90B | 1.61% | 225,090 | - |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.89B | 3.82% | 214,296 | - |
| 116 | OCUL | Ocular Therapeutix, Inc. | 1.89B | 1.23% | 787,784 | 52.04M |
| 117 | FBRX | Forte Biosciences, Inc. | 1.87B | 39.54% | 15,586,714 | - |
| 118 | BCAX | Bicara Therapeutics Inc. | 1.86B | 4.81% | 285,261 | - |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 0.24% | 492,874 | 217.17M |
| 120 | LKFT | Lakefront Biotherapeutics NV | 1.84B | 1.17% | 82,400 | 1.20B |
| 121 | STOK | Stoke Therapeutics, Inc. | 1.84B | 0.68% | 259,740 | 32.08M |
| 122 | DMRA | Damora Therapeutics, Inc. | 1.83B | 3.04% | 405,370 | - |
| 123 | TSHA | Taysha Gene Therapies, Inc. | 1.82B | 3.08% | 1,089,925 | 7.47M |
| 124 | FTRE | Fortrea Holdings Inc. | 1.82B | -1.59% | 742,833 | 2.71B |
| 125 | GENB | Generate Biomedicines, Inc. | 1.76B | 2.61% | 183,898 | 30.30M |
| 126 | IMCR | Immunocore Holdings plc | 1.74B | -2.51% | 189,572 | 412.81M |
| 127 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.73B | -0.74% | 1,329,375 | 204.73M |
| 128 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | 3.64% | 2,080,027 | 2.18B |
| 129 | AAPG | Ascentage Pharma Group International | 1.69B | 3.28% | 1,057 | 82.08M |
| 130 | ZYME | Zymeworks Inc. | 1.66B | 1.53% | 116,191 | 81.26M |
| 131 | MLTX | MoonLake Immunotherapeutics | 1.64B | 4.31% | 655,533 | - |
| 132 | ABCL | AbCellera Biologics Inc. | 1.62B | -0.38% | 3,021,990 | 79.21M |
| 133 | ANAB | AnaptysBio, Inc. | 1.61B | 0.22% | 187,008 | 232.39M |
| 134 | RXRX | Recursion Pharmaceuticals, Inc. | 1.59B | 1.52% | 17,122,310 | 66.41M |
| 135 | INVA | Innoviva, Inc. | 1.59B | 0.56% | 367,541 | 420.69M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.58B | 3.27% | 139,207 | 20.00M |
| 137 | NTLA | Intellia Therapeutics, Inc. | 1.51B | 1.03% | 1,754,731 | 66.09M |
| 138 | SEPN | Septerna, Inc. | 1.51B | 1.12% | 82,020 | 72.26M |
| 139 | VIR | Vir Biotechnology, Inc. | 1.50B | 2.53% | 835,256 | 65.50M |
| 140 | TRAX | First Tracks Biotherapeutics, Inc. | 1.50B | 20.78% | 2,091,538 | - |
| 141 | XNCR | Xencor, Inc. | 1.50B | 3.76% | 514,590 | 97.36M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -3.06% | 490,142 | - |
| 143 | SVRA | Savara Inc. | 1.40B | 0.54% | 3,011,807 | - |
| 144 | AKTS | Aktis Oncology, Inc. | 1.37B | 3.60% | 184,509 | 8.28M |
| 145 | ABSI | Absci Corporation | 1.30B | 1.32% | 1,528,542 | 1.84M |
| 146 | ARDX | Ardelyx, Inc. | 1.27B | 1.99% | 953,733 | 427.68M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 1.16% | 887,937 | - |
| 148 | MNKD | MannKind Corporation | 1.25B | -1.69% | 2,361,529 | 360.78M |
| 149 | NVAX | Novavax, Inc. | 1.25B | 1.68% | 1,767,964 | 596.34M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.23B | -0.64% | 112,680 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.21B | 1.29% | 1,063,227 | - |
| 152 | IMTX | Immatics N.V. | 1.20B | -2.97% | 273,672 | 43.00M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.19B | -0.37% | 107,190 | 1.30M |
| 154 | MGTX | MeiraGTx Holdings plc | 1.15B | 5.35% | 373,271 | 79.76M |
| 155 | WVE | Wave Life Sciences Ltd. | 1.14B | 2.41% | 1,056,715 | 71.80M |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 0.57% | 66,808 | - |
| 157 | DRTS | Alpha Tau Medical Ltd. | 1.11B | -1.60% | 255,601 | - |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | 4.85% | 238,428 | - |
| 159 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -0.15% | 404,328 | - |
| 160 | OLMA | Olema Pharmaceuticals, Inc. | 1.09B | 6.32% | 583,775 | - |
| 161 | VOR | Vor Biopharma Inc. | 1.08B | 3.32% | 647,179 | - |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.07B | 2.69% | 153,829 | - |
| 163 | IVA | Inventiva S.A. | 1.05B | 2.02% | 485,005 | 7.94M |
| 164 | EYPT | EyePoint, Inc. | 1.05B | 2.54% | 813,257 | 7.61M |
| 165 | AVTX | Avalo Therapeutics, Inc. | 1.04B | 7.10% | 537,609 | 59.00K |
| 166 | SANA | Sana Biotechnology, Inc. | 1.00B | 5.03% | 2,095,101 | - |
| 167 | LBRX | LB Pharmaceuticals Inc | 987.91M | -1.60% | 166,231 | - |
| 168 | JANX | Janux Therapeutics, Inc. | 965.38M | 3.26% | 1,060,412 | 13.73M |
| 169 | LXRX | Lexicon Pharmaceuticals, Inc. | 963.91M | -5.24% | 2,116,452 | 69.64M |
| 170 | GERN | Geron Corporation | 946.24M | 3.87% | 4,219,658 | 196.12M |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 942.04M | 3.67% | 339,336 | 204.89M |
| 172 | KURA | Kura Oncology, Inc. | 925.03M | 0.29% | 514,483 | 71.64M |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 905.37M | 1.34% | 82,495 | 1.06M |
| 174 | PHAR | Pharming Group N.V. | 886.13M | 3.05% | 5,611 | 369.49M |
| 175 | ABUS | Arbutus Biopharma Corporation | 877.07M | 1.37% | 407,699 | 191.45M |
| 176 | TBPH | Theravance Biopharma, Inc. | 874.60M | 0.09% | 234,465 | 109.78M |
| 177 | ANNX | Annexon, Inc. | 871.64M | 1.92% | 649,453 | - |
| 178 | TENX | Tenax Therapeutics, Inc. | 825.13M | 11.15% | 1,089,333 | - |
| 179 | OMER | Omeros Corporation | 821.46M | 15.93% | 2,682,570 | 9.89M |
| 180 | DBVT | DBV Technologies S.A. | 801.87M | 0.84% | 266,080 | 5.04M |
| 181 | AURA | Aura Biosciences, Inc. | 791.95M | 1.84% | 164,136 | - |
| 182 | SLDB | Solid Biosciences Inc. | 789.57M | 2.43% | 478,026 | - |
| 183 | DSGN | Design Therapeutics, Inc. | 749.48M | 1.87% | 171,105 | - |
| 184 | FTH | Faeth Therapeutics, Inc. | 743.72M | 1.98% | 290,518 | - |
| 185 | CADL | Candel Therapeutics, Inc. | 742.96M | 6.07% | 835,116 | - |
| 186 | ACRS | Aclaris Therapeutics, Inc. | 732.54M | 0.29% | 3,612,928 | 8.37M |
| 187 | MNPR | Monopar Therapeutics Inc. | 729.80M | -0.84% | 281,577 | - |
| 188 | CTMX | CytomX Therapeutics, Inc. | 722.77M | 2.47% | 1,285,200 | 35.54M |
| 189 | REPL | Replimune Group, Inc. | 717.47M | -11.91% | 6,594,741 | - |
| 190 | CLYM | Climb Bio, Inc. | 710.60M | -3.35% | 852,983 | - |
| 191 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 709.75M | 0.45% | 81,554 | - |
| 192 | RIGL | Rigel Pharmaceuticals, Inc. | 709.74M | 4.41% | 110,324 | 299.77M |
| 193 | CBIO | Crescent Biopharma, Inc. | 706.22M | 4.85% | 115,185 | 11.88M |
| 194 | DRUG | Bright Minds Biosciences Inc. | 697.64M | 2.05% | 142,518 | - |
| 195 | NGNE | Neurogene Inc. | 693.46M | -0.29% | 89,226 | 925.00K |
| 196 | SGP | SpyGlass Pharma, Inc. | 687.06M | 0.29% | 30,162 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 681.20M | 2.86% | 15,662 | 117.05M |
| 198 | OCS | Oculis Holding AG | 675.74M | 0.54% | 254,677 | 1.40M |
| 199 | MDXG | MiMedx Group, Inc. | 647.91M | 3.57% | 561,946 | 389.42M |
| 200 | IMMX | Immix Biopharma, Inc. | 632.17M | 4.23% | 1,387,968 | - |
| 201 | ACHV | Achieve Life Sciences, Inc. | 630.33M | 0.66% | 654,761 | - |
| 202 | AGMB | AgomAb Therapeutics NV | 612.89M | -0.52% | 21,631 | - |
| 203 | ALLO | Allogene Therapeutics, Inc. | 612.65M | 2.01% | 4,581,636 | 22.00K |
| 204 | NVCT | Nuvectis Pharma, Inc. | 608.92M | 0.03% | 96,774 | - |
| 205 | CRMD | CorMedix Inc. | 608.00M | -1.52% | 603,953 | 400.05M |
| 206 | RGNX | REGENXBIO Inc. | 604.07M | 0.62% | 771,843 | 87.82M |
| 207 | TECX | Tectonic Therapeutic, Inc. | 579.66M | 1.15% | 115,893 | - |
| 208 | ALT | Altimmune, Inc. | 571.75M | 6.14% | 2,137,070 | 36.00K |
| 209 | SLN | Silence Therapeutics plc | 567.75M | 9.07% | 402,496 | 839.00K |
| 210 | ZVRA | Zevra Therapeutics, Inc. | 567.50M | 0.79% | 1,101,530 | 122.29M |
| 211 | STTK | Shattuck Labs, Inc. | 567.44M | -0.40% | 581,493 | 1.00M |
| 212 | SPRY | ARS Pharmaceuticals, Inc. | 560.07M | -5.05% | 1,060,708 | 98.99M |
| 213 | PRME | Prime Medicine, Inc. | 553.59M | 3.90% | 1,572,614 | 4.03M |
| 214 | RLMD | Relmada Therapeutics, Inc. | 547.53M | 0.77% | 419,843 | - |
| 215 | VSTM | Verastem, Inc. | 546.57M | 2.81% | 1,142,416 | 49.59M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 539.49M | 2.48% | 256,666 | 88.24M |
| 217 | ARVN | Arvinas, Inc. | 533.59M | 2.99% | 280,367 | 89.40M |
| 218 | EIKN | Eikon Therapeutics, Inc. | 527.31M | 9.44% | 112,240 | - |
| 219 | CTNM | Contineum Therapeutics, Inc. | 523.04M | -0.50% | 55,916 | - |
| 220 | ZURA | Zura Bio Limited | 518.69M | 4.40% | 250,466 | - |
| 221 | RZLT | Rezolute, Inc. | 513.98M | -1.40% | 637,541 | - |
| 222 | ASMB | Assembly Biosciences, Inc. | 503.22M | 2.31% | 45,194 | 71.10M |
| 223 | ARTV | Artiva Biotherapeutics, Inc. | 502.89M | 3.19% | 214,923 | 251.00K |
| 224 | MPLT | MapLight Therapeutics, Inc. | 499.26M | -69.89% | 5,824,084 | - |
| 225 | KYTX | Kyverna Therapeutics, Inc. | 489.40M | 8.64% | 844,207 | - |
| 226 | ANL | Adlai Nortye Ltd. | 486.00M | -2.80% | 68,340 | 5.00M |
| 227 | DNA | Ginkgo Bioworks Holdings, Inc. | 484.71M | 0.82% | 342,165 | 151.40M |
| 228 | HELP | Cybin Inc. | 479.76M | 1.57% | 737,563 | - |
| 229 | PROK | ProKidney Corp. | 466.68M | 3.00% | 1,002,889 | 889.00K |
| 230 | SGMT | Sagimet Biosciences Inc. | 460.67M | 5.52% | 302,407 | - |
| 231 | PRTA | Prothena Corporation plc | 458.09M | - | 411,567 | 57.94M |
| 232 | IKT | Inhibikase Therapeutics, Inc. | 457.29M | 0.43% | 395,607 | 1.00 |
| 233 | VALN | Valneva SE | 455.82M | 4.39% | 2,569 | 180.25M |
| 234 | CABA | Cabaletta Bio, Inc. | 450.03M | 2.60% | 1,390,502 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 448.87M | 3.22% | 567,555 | 7.12M |
| 236 | SLBT | SL Science Holding Limited | 444.47M | -11.86% | 90,756 | 3.36M |
| 237 | OCGN | Ocugen, Inc. | 433.31M | 5.79% | 1,649,447 | 4.47M |
| 238 | EVMN | Evommune, Inc. | 417.81M | 2.11% | 153,996 | 10.00M |
| 239 | EDIT | Editas Medicine, Inc. | 413.58M | 3.65% | 651,860 | 38.69M |
| 240 | PBYI | Puma Biotechnology, Inc. | 408.47M | 0.56% | 58,644 | 227.18M |
| 241 | CCCC | C4 Therapeutics, Inc. | 405.78M | 7.94% | 3,599,664 | 34.86M |
| 242 | LRMR | Larimar Therapeutics, Inc. | 400.83M | -4.00% | 1,264,990 | - |
| 243 | STRO | Sutro Biopharma, Inc. | 400.42M | 5.62% | 128,116 | 99.61M |
| 244 | BNTC | Benitec Biopharma Inc. | 396.79M | 0.70% | 32,701 | - |
| 245 | CAPR | Capricor Therapeutics, Inc. | 395.83M | -65.30% | 26,165,192 | 11.13M |
| 246 | AUTL | Autolus Therapeutics plc | 392.56M | 1.72% | 421,511 | 92.62M |
| 247 | PRLD | Prelude Therapeutics Incorporated | 390.76M | 2.87% | 85,363 | 16.72M |
| 248 | AVIR | Atea Pharmaceuticals, Inc. | 389.33M | 2.85% | 67,225 | - |
| 249 | CMPX | Compass Therapeutics, Inc. | 385.39M | 3.38% | 2,046,882 | 850.00K |
| 250 | VTVT | vTv Therapeutics Inc. | 384.32M | 0.78% | 51,704 | 36.84M |
| 251 | EPRX | Eupraxia Pharmaceuticals Inc. | 381.30M | 5.34% | 188,309 | - |
| 252 | IPSC | Century Therapeutics, Inc. | 378.75M | -0.47% | 328,489 | 109.16M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 375.40M | 1.02% | 35,762 | 69.21M |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 373.51M | 2.86% | 183,799 | 9.01M |
| 255 | DMAC | DiaMedica Therapeutics Inc. | 365.33M | 0.67% | 30,117 | - |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 358.70M | 2.98% | 870,051 | - |
| 257 | LXEO | Lexeo Therapeutics, Inc. | 358.06M | -2.15% | 386,636 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 357.79M | 3.10% | 74,847 | 51.00M |
| 259 | ABEO | Abeona Therapeutics Inc. | 350.52M | 1.65% | 521,287 | 14.54M |
| 260 | PALI | Palisade Bio, Inc. | 346.29M | 2.31% | 892,782 | - |
| 261 | UPB | Upstream Bio, Inc. | 345.57M | -0.94% | 270,241 | 3.32M |
| 262 | VCRE | Vicore Pharma Holding AB (publ) | 326.47M | -0.35% | 518 | 370.61K |
| 263 | SCTX | Scribe Therapeutics Inc. | 326.00M | -14.50% | 334,021 | 36.28M |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 323.19M | 4.85% | 399,910 | 26.87M |
| 265 | LYEL | Lyell Immunopharma, Inc. | 316.35M | 2.22% | 78,876 | 31.00K |
| 266 | VNDA | Vanda Pharmaceuticals Inc. | 316.01M | 1.45% | 370,087 | 217.78M |
| 267 | NMRA | Neumora Therapeutics, Inc. | 306.65M | 11.07% | 550,089 | - |
| 268 | FHTX | Foghorn Therapeutics Inc. | 300.62M | 5.57% | 109,227 | 28.22M |
| 269 | OABI | OmniAb, Inc. | 295.02M | 0.25% | 172,187 | 28.94M |
| 270 | FATE | Fate Therapeutics, Inc. | 283.24M | 0.83% | 370,607 | 6.32M |
| 271 | IMRX | Immuneering Corporation | 282.08M | 0.93% | 346,682 | - |
| 272 | BCYC | Bicycle Therapeutics plc | 277.85M | 2.84% | 187,785 | 63.50M |
| 273 | ALXO | ALX Oncology Holdings Inc. | 277.20M | 1.48% | 251,442 | - |
| 274 | ELDN | Eledon Pharmaceuticals, Inc. | 276.74M | - | 958,189 | - |
| 275 | IRD | Opus Genetics, Inc. | 275.77M | 8.44% | 344,441 | 11.98M |
| 276 | AGEN | Agenus Inc. | 274.33M | 2.51% | 952,587 | 123.87M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 266.10M | -0.85% | 497,642 | 114.70K |
| 278 | SLGL | Sol-Gel Technologies Ltd. | 264.66M | -1.22% | 36,112 | 18.47M |
| 279 | NAGE | Niagen Bioscience, Inc. | 258.59M | 0.93% | 267,468 | 130.42M |
| 280 | QTTB | Q32 Bio Inc. | 258.59M | 0.66% | 405,603 | 53.74M |
| 281 | LCTX | Lineage Cell Therapeutics, Inc. | 256.78M | - | 1,451,882 | 14.78M |
| 282 | IFRX | InflaRx N.V. | 253.33M | -1.16% | 654,745 | 33.82K |
| 283 | MGNX | MacroGenics, Inc. | 251.07M | 6.76% | 399,971 | 157.08M |
| 284 | FULC | Fulcrum Therapeutics, Inc. | 249.87M | 0.81% | 337,719 | 80.00M |
| 285 | PRQR | ProQR Therapeutics N.V. | 247.67M | 2.03% | 505,440 | 15.73M |
| 286 | TTRX | Turn Therapeutics Inc. | 238.30M | -6.32% | 53,155 | - |
| 287 | INDP | Indaptus Therapeutics, Inc. | 237.81M | -19.54% | 240,478 | - |
| 288 | RNAC | Cartesian Therapeutics, Inc. | 234.02M | 1.08% | 47,302 | 1.78M |
| 289 | AVXL | Anavex Life Sciences Corp. | 234.00M | 5.21% | 488,467 | - |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 228.44M | 2.01% | 143,805 | 32.72M |
| 291 | ADAG | Adagene Inc. | 227.69M | 7.69% | 137,713 | 7.67M |
| 292 | TARA | Protara Therapeutics, Inc. | 226.78M | 0.37% | 274,283 | - |
| 293 | ACIU | AC Immune SA | 226.67M | 2.47% | 105,050 | 4.62M |
| 294 | CHRS | Coherus Oncology, Inc. | 225.98M | 3.90% | 374,324 | 46.88M |
| 295 | CGEN | Compugen Ltd. | 224.17M | 3.95% | 79,507 | 72.66M |
| 296 | SRZN | Surrozen, Inc. | 222.34M | -2.94% | 88,044 | 7.49M |
| 297 | GALT | Galectin Therapeutics Inc. | 221.28M | -3.17% | 214,678 | - |
| 298 | TRDA | Entrada Therapeutics, Inc. | 217.64M | 3.25% | 233,367 | 5.74M |
| 299 | NAUT | Nautilus Biotechnology, Inc. | 214.76M | - | 254,835 | - |
| 300 | CLLS | Cellectis S.A. | 210.60M | - | 1,418 | 75.11M |
| 301 | NBP | NovaBridge Biosciences | 208.17M | 1.69% | 118,350 | - |
| 302 | OTLK | Outlook Therapeutics, Inc. | 205.70M | -21.71% | 36,992,417 | 333.14K |
| 303 | KROS | Keros Therapeutics, Inc. | 204.65M | 2.78% | 101,756 | 33.18M |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 201.69M | 1.08% | 493,186 | 7.15M |
| 305 | CNXU | Conexeu Sciences Inc. | 200.69M | -12.49% | 125,690 | - |
| 306 | RNA | Atrium Therapeutics, Inc. | 199.96M | 1.74% | 53,756 | 36.68M |
| 307 | GLSI | Greenwich LifeSciences, Inc. | 199.04M | 4.47% | 93,166 | - |
| 308 | NERV | Minerva Neurosciences, Inc. | 195.67M | 3.96% | 109,122 | - |
| 309 | PLX | Protalix BioTherapeutics, Inc. | 192.97M | 1.05% | 434,003 | 76.38M |
| 310 | IMUX | Immunic, Inc. | 191.18M | 4.82% | 80,641 | - |
| 311 | ENTX | Entera Bio Ltd. | 190.26M | 88.29% | 77,497,940 | 42.00K |
| 312 | DTIL | Precision BioSciences, Inc. | 189.39M | 0.69% | 167,893 | 45.07M |
| 313 | MDWD | MediWound Ltd. | 187.77M | 2.67% | 13,646 | 14.48M |
| 314 | VYGR | Voyager Therapeutics, Inc. | 186.10M | -0.65% | 469,008 | 36.49M |
| 315 | PYXS | Pyxis Oncology, Inc. | 185.63M | 12.26% | 764,173 | 13.86M |
| 316 | ACOG | Alpha Cognition Inc. | 183.99M | 6.96% | 76,462 | 10.83M |
| 317 | MENS | Jyong Biotech Ltd. | 182.99M | 4.45% | 16,812 | - |
| 318 | LENZ | LENZ Therapeutics, Inc. | 180.29M | 4.93% | 780,098 | 20.99M |
| 319 | HUMA | Humacyte, Inc. | 180.25M | 6.99% | 3,088,094 | 2.02M |
| 320 | IVVD | Invivyd, Inc. | 178.71M | -0.79% | 3,108,956 | 55.87M |
| 321 | CAMP | Camp4 Therapeutics Corporation | 177.59M | 8.23% | 175,161 | 3.93M |
| 322 | ANTX | AN2 Therapeutics, Inc. | 177.56M | 0.20% | 15,063 | - |
| 323 | NGEN | NervGen Pharma Corp. | 176.30M | 1.84% | 237,477 | - |
| 324 | ARMP | Armata Pharmaceuticals, Inc. | 174.74M | 2.15% | 57,281 | 5.20M |
| 325 | IPHA | Innate Pharma S.A. | 169.81M | 2.25% | 1,756 | 10.57M |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 169.34M | -0.33% | 309,310 | - |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 169.25M | 2.62% | 43,715 | 2.00M |
| 328 | ALEC | Alector, Inc. | 168.20M | 2.36% | 72,475 | 18.42M |
| 329 | TNYA | Tenaya Therapeutics, Inc. | 167.37M | -0.48% | 720,120 | 225.00K |
| 330 | OKUR | OnKure Therapeutics, Inc. | 166.03M | -0.24% | 24,098 | - |
| 331 | YDES | YD Bio Limited | 165.95M | 5.36% | 21,025 | 510.36K |
| 332 | NKTX | Nkarta, Inc. | 165.27M | 1.76% | 600,526 | - |
| 333 | TNXP | Tonix Pharmaceuticals Holding Corp. | 164.67M | 4.55% | 304,171 | 17.56M |
| 334 | ARCT | Arcturus Therapeutics Holdings Inc. | 163.43M | 3.98% | 268,786 | 54.71M |
| 335 | KPTI | Karyopharm Therapeutics Inc. | 162.72M | -3.10% | 357,798 | 151.12M |
| 336 | EQ | Equillium, Inc. | 160.28M | 1.81% | 209,249 | 4.39M |
| 337 | CRBU | Caribou Biosciences, Inc. | 160.18M | 2.87% | 475,512 | 11.20M |
| 338 | ABOS | Acumen Pharmaceuticals, Inc. | 159.62M | 3.76% | 167,701 | - |
| 339 | CNTN | Canton Strategic Holdings, Inc. | 158.87M | 6.19% | 535,637 | - |
| 340 | MIST | Milestone Pharmaceuticals Inc. | 154.42M | -2.16% | 1,049,350 | 1.78M |
| 341 | KRRO | Korro Bio, Inc. | 153.02M | -0.28% | 69,336 | 3.84M |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 150.46M | -4.27% | 696,063 | 2.29M |
| 343 | MOLN | Molecular Partners AG | 148.52M | 2.96% | 638 | 856.30K |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 141.90M | -4.07% | 471,860 | - |
| 345 | AARD | Aardvark Therapeutics, Inc. | 140.72M | 2.06% | 30,716 | - |
| 346 | HURA | TuHURA Biosciences, Inc. | 139.78M | 4.03% | 95,749 | - |
| 347 | KZIA | Kazia Therapeutics Limited | 138.89M | -0.86% | 128,227 | 1.27M |
| 348 | CDXS | Codexis, Inc. | 138.16M | 2.70% | 3,129,052 | 78.09M |
| 349 | CUE | Cue Biopharma, Inc. | 136.20M | 0.95% | 186,345 | 32.73M |
| 350 | CNTB | Connect Biopharma Holdings Limited | 134.74M | - | 133,940 | 233.00K |
| 351 | CBUS | Cibus, Inc. | 134.34M | 3.53% | 105,213 | 4.29M |
| 352 | PEPG | PepGen Inc. | 132.11M | -1.04% | 421,900 | - |
| 353 | GNLX | Genelux Corporation | 129.67M | 1.04% | 25,740 | 8.00K |
| 354 | GUTS | Fractyl Health, Inc. | 127.24M | 3.75% | 1,301,423 | 3.00K |
| 355 | ENGN | enGene Therapeutics Inc. | 120.58M | -1.10% | 416,196 | - |
| 356 | TLSA | Tiziana Life Sciences Ltd | 119.54M | 3.59% | 81,141 | - |
| 357 | SPRB | Spruce Biosciences, Inc. | 119.17M | 0.51% | 43,107 | 697.00K |
| 358 | ANIX | Anixa Biosciences, Inc. | 113.64M | -9.73% | 378,430 | - |
| 359 | VANI | Vivani Medical, Inc. | 112.11M | 1.56% | 78,087 | - |
| 360 | FBIO | Fortress Biotech, Inc. | 107.96M | -2.69% | 356,970 | 66.16M |
| 361 | SEER | Seer, Inc. | 106.11M | -2.03% | 2,203,316 | 15.17M |
| 362 | PMN | ProMIS Neurosciences, Inc. | 102.41M | -6.39% | 64,726 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 101.71M | 0.85% | 267,389 | 70.00M |
| 364 | ICCC | ImmuCell Corporation | 100.92M | 1.13% | 8,617 | 29.93M |
| 365 | COYA | Coya Therapeutics, Inc. | 100.68M | 0.99% | 45,508 | 7.94M |
| 366 | RANI | Rani Therapeutics Holdings, Inc. | 99.76M | -5.36% | 764,832 | 3.17M |
| 367 | ONCY | Oncolytics Biotech Inc. | 96.15M | -0.81% | 807,776 | - |
| 368 | PTHS | Pelthos Therapeutics Inc. | 95.39M | 5.88% | 89,701 | 27.70M |
| 369 | ALDX | Aldeyra Therapeutics, Inc. | 93.80M | 2.30% | 851,235 | - |
| 370 | PLYX | Polaryx Therapeutics, Inc. | 92.79M | -4.39% | 129,440 | - |
| 371 | BMEA | Biomea Fusion, Inc. | 92.18M | 2.00% | 319,049 | - |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 90.02M | 4.38% | 99,125 | 37.16M |
| 373 | GOSS | Gossamer Bio, Inc. | 89.70M | 34.93% | 258,596,016 | 55.54M |
| 374 | BIOT | Instinct Brothers Co., Ltd. | 88.47M | -80.19% | 469,714 | - |
| 375 | NTHI | NeOnc Technologies Holdings, Inc. | 88.43M | -0.58% | 10,225 | 39.99K |
| 376 | HRTX | Heron Therapeutics, Inc. | 88.10M | 2.12% | 1,753,278 | 150.71M |
| 377 | RLYB | Rallybio Corporation | 86.39M | -0.03% | 14,412 | 858.00K |
| 378 | OKYO | OKYO Pharma Limited | 86.07M | 5.81% | 102,634 | - |
| 379 | ATHE | Alterity Therapeutics Limited | 85.94M | 0.22% | 3,214 | 4.43M |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 85.65M | -3.49% | 56,731 | - |
| 381 | ACET | Adicet Bio, Inc. | 85.37M | 4.36% | 85,906 | - |
| 382 | CSBR | Champions Oncology, Inc. | 85.24M | 0.14% | 987 | 57.95M |
| 383 | CGTX | Cognition Therapeutics, Inc. | 83.46M | 1.42% | 244,544 | - |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 83.22M | 5.22% | 59,363 | - |
| 385 | NRXS | NeurAxis, Inc. | 83.00M | -1.44% | 96,396 | 4.28M |
| 386 | INO | Inovio Pharmaceuticals, Inc. | 79.55M | -0.33% | 1,466,949 | 65.34K |
| 387 | MAIA | MAIA Biotechnology, Inc. | 78.43M | 4.03% | 297,111 | - |
| 388 | GANX | Gain Therapeutics, Inc. | 78.27M | 4.86% | 276,613 | - |
| 389 | ALPS | Alps Group Inc | 77.38M | -0.26% | 13,110 | 3.74M |
| 390 | PYPD | PolyPid Ltd. | 75.93M | 1.54% | 58,579 | - |
| 391 | RNTX | Rein Therapeutics Inc. | 72.06M | -2.12% | 254,024 | - |
| 392 | ANVS | Annovis Bio, Inc. | 71.26M | 0.90% | 327,328 | - |
| 393 | ELTX | Elicio Therapeutics, Inc. | 70.82M | 0.67% | 157,058 | - |
| 394 | ATRA | Atara Biotherapeutics, Inc. | 70.19M | -1.39% | 33,549 | 23.14M |
| 395 | IBIO | iBio, Inc. | 69.55M | -2.10% | 531,475 | 300.00K |
| 396 | LONA | LeonaBio, Inc. | 69.32M | -0.14% | 12,427 | - |
| 397 | SPRO | Spero Therapeutics, Inc. | 68.90M | - | 734,282 | 61.19M |
| 398 | XBIT | XBiotech Inc. | 68.90M | -0.44% | 25,287 | - |
| 399 | OSTX | OS Therapies Incorporated | 68.14M | 0.66% | 166,990 | - |
| 400 | PLRX | Pliant Therapeutics, Inc. | 67.18M | -0.46% | 172,849 | - |
| 401 | ENLV | Enlivex Ltd. | 66.85M | -0.95% | 48,830 | - |
| 402 | HYFT | MindWalk Holdings Corp. | 66.80M | 5.15% | 356,991 | 11.43M |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 66.77M | -2.50% | 129,373 | - |
| 404 | MNOV | MediciNova, Inc. | 64.48M | -0.76% | 12,776 | 596.64K |
| 405 | IMA | ImageneBio, Inc. | 63.16M | 0.18% | 10,670 | 800.00K |
| 406 | PMVP | PMV Pharmaceuticals, Inc. | 62.66M | -5.24% | 193,809 | - |
| 407 | CING | Cingulate Inc. | 61.62M | -1.40% | 127,312 | - |
| 408 | CNTX | Context Therapeutics Inc. | 58.69M | 4.02% | 1,088,275 | - |
| 409 | CRDF | Cardiff Oncology, Inc. | 57.76M | 2.16% | 641,264 | 525.00K |
| 410 | BOLD | Boundless Bio, Inc. | 56.04M | -2.92% | 104,848 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 54.80M | -0.63% | 4,319 | - |
| 412 | XLO | Xilio Therapeutics, Inc. | 52.95M | 2.31% | 29,249 | 53.48M |
| 413 | VRXA | Veraxa Biotech AG | 51.19M | 12.78% | 613,050 | - |
| 414 | TCRX | TScan Therapeutics, Inc. | 51.04M | -1.63% | 729,094 | 9.14M |
| 415 | DWTX | Dogwood Therapeutics, Inc. | 50.44M | - | 1,996 | - |
| 416 | IMMP | Immutep Limited | 49.47M | 1.74% | 159,192 | 5.28M |
| 417 | TIL | Instil Bio, Inc. | 48.39M | 0.07% | 12,971 | - |
| 418 | BYSI | BeyondSpring Inc. | 48.11M | 4.47% | 4,076 | 1.88M |
| 419 | MREO | Mereo BioPharma Group plc | 47.93M | 4.34% | 1,194,860 | 500.00K |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 47.47M | -1.51% | 21,530 | - |
| 421 | MCRB | Seres Therapeutics, Inc. | 47.40M | -1.41% | 61,011 | 1.15M |
| 422 | ATYR | aTyr Pharma, Inc. | 47.36M | 2.05% | 490,884 | 190.00K |
| 423 | EDSA | Edesa Biotech, Inc. | 47.13M | 0.95% | 50,179 | - |
| 424 | IBO | Impact BioMedical Inc. | 46.37M | -2.25% | 5,844 | 39.00K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 45.56M | 0.42% | 37,271 | 22.33M |
| 426 | INMB | INmune Bio Inc. | 45.46M | 5.56% | 127,093 | 50.00K |
| 427 | FLNA | Filana Therapeutics, Inc. | 43.96M | 2.14% | 184,069 | - |
| 428 | RNXT | RenovoRx, Inc. | 43.52M | 11.52% | 794,766 | 1.49M |
| 429 | DYAI | Dyadic International, Inc. | 42.47M | -2.05% | 71,744 | 3.81M |
| 430 | APLM | Apollomics, Inc. | 39.53M | -1.15% | 10,282 | 8.84M |
| 431 | HYPD | Hyperion DeFi, Inc. | 38.35M | 0.80% | 98,977 | 1.04M |
| 432 | GNTA | Genenta Science S.p.A. | 38.22M | 1.89% | 33,831 | - |
| 433 | EXOZ | eXoZymes, Inc. | 38.16M | -4.46% | 10,021 | -700.00 |
| 434 | GRCE | Grace Therapeutics, Inc. | 38.08M | 0.43% | 82,297 | - |
| 435 | VERU | Veru Inc. | 37.88M | 4.89% | 303,300 | 16.89M |
| 436 | PDSB | PDS Biotechnology Corporation | 37.54M | -1.29% | 277,388 | - |
| 437 | LTRN | Lantern Pharma Inc. | 36.75M | 4.73% | 18,077 | - |
| 438 | NTRB | Nutriband Inc. | 35.98M | -0.67% | 6,248 | 1.80M |
| 439 | NNVC | NanoViricides, Inc. | 35.65M | 5.74% | 439,537 | - |
| 440 | CRVO | CervoMed Inc. | 35.03M | -2.63% | 278,191 | 2.09M |
| 441 | RADX | Radiopharm Theranostics Limited | 34.70M | 3.38% | 326,895 | 10.86M |
| 442 | ESLA | Estrella Immunopharma, Inc. | 33.34M | -0.67% | 15,895 | - |
| 443 | LITS | Lite Strategy, Inc. | 33.02M | -1.82% | 197,457 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 31.07M | -2.23% | 35,095 | - |
| 445 | SER | Serina Therapeutics, Inc. | 30.59M | -1.45% | 9,366 | 130.00K |
| 446 | KYNB | Kyntra Bio, Inc. | 28.54M | 0.28% | 4,169 | 7.44M |
| 447 | ACTU | Actuate Therapeutics, Inc. | 27.04M | -4.24% | 146,467 | - |
| 448 | ATNM | Actinium Pharmaceuticals, Inc. | 26.67M | -1.16% | 99,134 | 90.00K |
| 449 | IGC | IGC Pharma, Inc. | 26.26M | -0.61% | 61,415 | 1.11M |
| 450 | PLRZ | Polyrizon Ltd. | 26.09M | -5.04% | 110,448 | - |
| 451 | ABVC | ABVC BioPharma, Inc. | 26.03M | -10.43% | 82,979 | 797.92K |
| 452 | PSTV | Plus Therapeutics, Inc. | 25.78M | -2.22% | 25,143 | 5.18M |
| 453 | EVAX | Evaxion A/S | 24.90M | 0.84% | 8,920 | 7.53M |
| 454 | ALGS | Aligos Therapeutics, Inc. | 24.75M | -1.96% | 184,632 | 4.71M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 24.51M | -0.33% | 8,240 | 14.97M |
| 456 | TVRD | Tvardi Therapeutics, Inc. | 23.45M | -0.40% | 1,123,506 | - |
| 457 | CELU | Celularity Inc. | 22.35M | 2.97% | 16,968 | 26.55M |
| 458 | SKYE | Skye Bioscience, Inc. | 21.99M | -4.00% | 108,440 | - |
| 459 | NEUP | Neuphoria Therapeutics Inc. | 21.13M | 7.42% | 155,488 | -13.27K |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 20.86M | -2.01% | 74,033 | - |
| 461 | CVM | CEL-SCI Corporation | 20.62M | - | 90,835 | - |
| 462 | ATOS | Atossa Therapeutics, Inc. | 20.50M | 3.70% | 31,595 | - |
| 463 | HOWL | Werewolf Therapeutics, Inc. | 20.35M | -1.94% | 152,615 | 1.14M |
| 464 | GRDX | GridAI Technologies Corp. | 20.29M | 0.33% | 18,767 | - |
| 465 | MRKR | Marker Therapeutics, Inc. | 20.17M | -0.82% | 28,591 | 3.55M |
| 466 | TVGN | Tevogen Bio Holdings Inc. | 20.12M | 6.22% | 6,493 | - |
| 467 | DARE | Daré Bioscience, Inc. | 19.85M | 3.52% | 93,667 | 1.16M |
| 468 | CLRB | Cellectar Biosciences, Inc. | 19.74M | 2.49% | 22,036 | - |
| 469 | LGVN | Longeveron Inc. | 19.36M | 2.12% | 143,973 | 1.22M |
| 470 | NCEL | NewcelX Ltd. | 19.36M | -4.26% | 6,386 | - |
| 471 | ALLR | Allarity Therapeutics, Inc. | 19.25M | 1.68% | 14,710 | 345.00K |
| 472 | JSPR | Jasper Therapeutics, Inc. | 18.65M | -3.21% | 416,962 | - |
| 473 | NXTC | NextCure, Inc. | 18.46M | 20.52% | 690,600 | - |
| 474 | QNTM | Quantum BioPharma Ltd. | 18.17M | -5.01% | 14,652 | - |
| 475 | LPCN | Lipocine Inc. | 17.81M | 3.85% | 16,707 | 2.00M |
| 476 | QNCX | Quince Therapeutics, Inc. | 17.68M | 1.26% | 14,349 | - |
| 477 | PLUR | Pluri Inc. | 17.59M | -8.43% | 19,842 | 1.08M |
| 478 | PTN | Palatin Technologies, Inc. | 17.10M | 1.63% | 10,979 | 12.88M |
| 479 | VYNE | VYNE Therapeutics Inc. | 16.90M | -0.47% | 77,338 | 454.00K |
| 480 | MLEC | Moolec Science SA | 15.23M | 1.74% | 2,225 | 7.83M |
| 481 | OSRH | OSR Health, Inc. | 15.10M | 1.70% | 237,216 | 2.63M |
| 482 | KTTA | Pasithea Therapeutics Corp. | 15.04M | -1.10% | 215,904 | - |
| 483 | PASG | Passage Bio, Inc. | 14.69M | -7.29% | 10,636 | - |
| 484 | CYCN | Cyclerion Therapeutics, Inc. | 14.61M | -1.55% | 12,962 | 1.99M |
| 485 | ICU | SeaStar Medical Holding Corporation | 14.51M | -3.73% | 58,191 | 1.44M |
| 486 | AKTX | Akari Therapeutics, Plc | 14.44M | -5.17% | 41,061 | - |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 14.40M | 0.83% | 119,791 | 5.61M |
| 488 | HIND | Vyome Holdings, Inc. | 14.32M | -0.97% | 2,502 | 152.72K |
| 489 | TPST | Tempest Therapeutics, Inc. | 14.19M | 3.50% | 120,376 | - |
| 490 | LSTA | Lisata Therapeutics, Inc. | 13.35M | -12.25% | 102,532 | 170.00K |
| 491 | LEXX | Lexaria Bioscience Corp. | 13.14M | -5.19% | 89,387 | 194.00K |
| 492 | BLRX | BioLineRx Ltd. | 12.86M | 0.36% | 4,226 | 1.40M |
| 493 | COCP | Cocrystal Pharma, Inc. | 12.63M | 1.77% | 22,505 | 225.00K |
| 494 | KALA | KALA BIO, Inc. | 12.46M | 5.66% | 68,156 | - |
| 495 | PHIO | Phio Pharmaceuticals Corp. | 12.20M | 0.96% | 74,497 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 12.11M | 0.66% | 8,182 | - |
| 497 | GTBP | GT Biopharma, Inc. | 11.83M | 1.17% | 319,827 | - |
| 498 | MBRX | Moleculin Biotech, Inc. | 11.77M | 4.01% | 102,620 | - |
| 499 | INAB | IN8bio, Inc. | 11.72M | -0.83% | 16,512 | - |
| 500 | PBM | Psyence Biomedical Ltd. | 11.44M | 1.69% | 21,996 | - |